Working Group to Look At Guidelines, Mandates, Centers Role In Prevention, Cancer Control
In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes
ACS Board Accepts Hammer’s ffer, Will Support Construction Survey
Reexamine Mandates, Samuels Suggests
NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic
Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians
Tacoma Hospital Finds Cancer DRGs Are Profitable
Trending Stories
- Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Trump’s tariffs will likely affect cancer drugs and devices—and may deepen drug shortages